Zobrazeno 1 - 10
of 598
pro vyhledávání: '"Chih-Hung Hsu"'
Autor:
Kao-Jung Chang, Li-Yang Shiau, Shiuan-Chen Lin, Han-Ping Cheong, Ching-Yun Wang, Chun Ma, Yan-Wen Liang, Yi-Ping Yang, Po-Shen Ko, Chih-Hung Hsu, Shih-Hwa Chiou
Publikováno v:
Molecular Medicine, Vol 30, Iss 1, Pp 1-20 (2024)
Abstract N6-methyladenosine (m6A) RNA modification orchestrates cellular epitranscriptome through tuning the homeostasis of transcript stability, translation efficiency, and the transcript affinity toward RNA-binding proteins (RBPs). An aberrant m6A
Externí odkaz:
https://doaj.org/article/b30dd08c10fa428ba34a5d7d33ccc174
Publikováno v:
International Journal of Sustainable Engineering, Vol 17, Iss 1, Pp 1-28 (2024)
ABSTRACTWith global supply chains facing increasing complexity and uncertainty, mitigating sustainable supply chain risks (SSCRs) has become an important research topic. Industry 5.0 (I5.0) is a supplement to, and re-development of, Industry 4.0, but
Externí odkaz:
https://doaj.org/article/751e9491a25b4281b9d00b886fbab26f
Autor:
Ching-Yun Wang, Shiuan-Chen Lin, Kao-Jung Chang, Han-Ping Cheong, Sin-Rong Wu, Cheng-Hao Lee, Ming-Wei Chuang, Shih-Hwa Chiou, Chih-Hung Hsu, Po-Shen Ko
Publikováno v:
Heliyon, Vol 10, Iss 21, Pp e39731- (2024)
Acute myeloid leukemia (AML) establishes an immunosuppressive microenvironment that favors leukemic proliferation. The immune-suppressive cytokines altered antigen processing, and presentation collectively assist AML cells in escaping cytotoxic T-cel
Externí odkaz:
https://doaj.org/article/0001cda48d5940b9b687baadbf3fa768
Autor:
Yu-Yun Shao, Min-Shu Hsieh, Yi-Hsuan Lee, Hung-Wei Hsu, Rita Robin Wo, Han-Yu Wang, Ann-Lii Cheng, Chih-Hung Hsu
Publikováno v:
Heliyon, Vol 10, Iss 14, Pp e34289- (2024)
The anti-programmed death-ligand 1 (PD-L1) antibody is a standard therapy for advanced hepatocellular carcinoma (HCC). Tumor expression of PD-L1 can be induced upon stimulus. Because cyclin-dependent kinase 9 (CDK9) inhibition reduces the expression
Externí odkaz:
https://doaj.org/article/17d5b1d346e04280aa47dacdb32645f5
Autor:
Ken Kato, Yuichiro Doki, Ian Chau, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih‐Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria Ignez Braghiroli, Eva Holtved, Tomoki Makino, Mariela Blum Murphy, Carlos Amaya‐Chanaga, Apurva Patel, Nan Hu, Yasuhiro Matsumura, Yuko Kitagawa, Jaffer Ajani
Publikováno v:
Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract Background First‐line nivolumab plus chemotherapy and nivolumab plus ipilimumab both demonstrated significant overall survival (OS) benefit versus chemotherapy in previously untreated patients with advanced esophageal squamous cell carcino
Externí odkaz:
https://doaj.org/article/59c4231e83f941f6a4719927e06f1ef1
Autor:
Jhe‐Cyuan Guo, Chia‐Lang Hsu, Min‐Shu Hsieh, Chia‐Chi Lin, Ta‐Chen Huang, Hung‐Yang Kuo, Yu‐Yun Shao, Chih‐Hung Hsu
Publikováno v:
Thoracic Cancer, Vol 14, Iss 22, Pp 2216-2221 (2023)
Abstract Immune checkpoint inhibitors (ICIs) have demonstrated efficacy in advanced esophageal squamous cell carcinoma (ESCC). Heterogeneous responses to ICIs have been reported previously. Here, we describe a patient with advanced ESCC exhibiting a
Externí odkaz:
https://doaj.org/article/de78700a496347f09d35ff706fccb537
Autor:
Zhengyi Li, Haiyan Xu, Jiaqun Li, Xiao Xu, Junjiao Wang, Danya Wu, Jiateng Zhang, Juan Liu, Ziwei Xue, Guankai Zhan, Bobby Cheng Peow Tan, Di Chen, Yun-Shen Chan, Huck Hui Ng, Wanlu Liu, Chih-Hung Hsu, Dan Zhang, Yang Shen, Hongqing Liang
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Acquisition of new stem cell fates relies on the dissolution of the prior regulatory network sustaining the existing cell fates. Currently, extensive insights have been revealed for the totipotency regulatory network around the zygotic genom
Externí odkaz:
https://doaj.org/article/35b1d34d886b45658cb76ff50e98280b
Autor:
Tsung-Hao Liu, San-Chi Chen, Kun-Ming Rau, Li-Chun Lu, Po-Ting Lin, Yung-Yeh Su, Wei Teng, Shiue-Wei Lai, Ren-Hua Yeh, Tsui-Mai Kao, Pei-Chang Lee, Chi-Jung Wu, Chien-Hung Chen, Chih-Hung Hsu, Shi-Ming Lin, Yi-Hsiang Huang, Li-Tzong Chen, Ann-Lii Cheng, Ying-Chun Shen
Publikováno v:
Liver Cancer (2024)
Introduction The progression patterns, dispositions, and outcomes of patients with advanced hepatocellular carcinoma (HCC) who achieved durable responses with immunotherapy remain poorly characterized. Methods Patients with advanced HCC who received
Externí odkaz:
https://doaj.org/article/982567d91e37462383001cc9dc3d4719
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 1, Pp 4-8 (2023)
Externí odkaz:
https://doaj.org/article/2f7172297d384a9fa303577d7ba0f21e
Autor:
Yu-Yun Shao, Yin-Hsun Feng, Chia-Jui Yen, Tsai-Sheng Yang, Ying-Chun Shen, Yee Chao, Jen-Shi Chen, Ching-Yen Su, Wei-Jen Chen, Hwa-Lin Hsiang, Chih-Hung Hsu
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 12, Pp 2430-2437 (2022)
Background: The combination of bevacizumab and atezolizumab has been established as a standard first-line systemic treatment for unresectable hepatocellular carcinoma (HCC). We examined the treatment outcomes of patients in Taiwan who received the co
Externí odkaz:
https://doaj.org/article/b516aa283916436c9db4ed35dc672f2a